Search Results 1521-1530 of 18410 for Capsule

  1. Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Patient must be able to swallow capsules and not have the following conditions: Disease significantly affecting gastrointestinal function; Resection of the ...

  2. A Study of BBI608 Combined with Standard Chemotherapies in Adult Patients who have Pancreatic Cancer - Mayo Clinic

    Unable or unwilling to swallow BBI608 capsules daily; Uncontrolled chronic diarrhea ≥ grade 2 at baseline; Uncontrolled intercurrent illness including, but ...

  3. Sarcoma - Doctors and departments - Mayo Clinic

    ... Capsule endoscopy, Single balloon en...teroscopy, Double balloon enteroscopy, Polypectomy, Balloon-assisted enteroscopy, Endoscopic full-thickness resection ...

  4. Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors - Mayo Clinic

    Any lesion, whether induced by tumor, radiation or other conditions, which makes it difficult to swallow capsules or pills; Prior surgical procedures ...

  5. A Study to Evaluate AL102 to Treat Patients with Progressing Desmoid Tumors - Mayo Clinic

    Must be able to swallow whole capsules with no GI condition affecting absorption; nasogastric or G-tube administration is not allowed. Exclusion Criteria ...

  6. Clinical trials - Oncology (Medical)

    This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma ...

  7. Clinical trials - Oncology (Medical)

    This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma ...

  8. Clinical trials - Oncology (Medical)

    The PK part (how the body processes the drug) will enroll about 18 participants. All participants will take (Z)-endoxifen capsules daily. Twelve participants ...

  9. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules and tablets without difficulty.

  10. A Study of Selpercatinib to Treat Participants with RET-Mutant Medullary Thyroid Cancer - Mayo Clinic

    Ability to swallow capsules and comply with treatment, laboratory monitoring, and required clinic visits for the duration of study participation. Patients ...